TG Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Revenue	531.9	329	233.66	2.79	6.69	0.15	Upgrade
Revenue Growth (YoY)	100.88%	40.80%	8290.02%	-58.36%	4300.66%	-	Upgrade
Cost of Revenue	77.97	38.49	14.13	0.27	0.79	-	Upgrade
Gross Profit	453.93	290.52	219.53	2.52	5.9	0.15	Upgrade
Selling, General & Admin	208.25	154.3	122.71	95.48	128.09	107.85	Upgrade
Research & Development	142.9	94.29	76.19	125.35	222.58	165.9	Upgrade
Operating Expenses	351.15	248.59	198.9	220.84	350.67	273.75	Upgrade
Operating Income	102.78	41.93	20.63	-218.32	-344.77	-273.59	Upgrade
Interest Expense	-27.26	-24.03	-12.62	-10.19	-5.64	-6.33	Upgrade
Other Non Operating Income (Expenses)	12.23	7.69	5.04	4.7	2.31	0.54	Upgrade
Pretax Income	87.75	25.59	13.06	-223.81	-348.1	-279.38	Upgrade
Income Tax Expense	-359.72	2.21	0.39	-	-	-	Upgrade
Net Income	447.47	23.38	12.67	-223.81	-348.1	-279.38	Upgrade
Net Income to Common	447.47	23.38	12.67	-223.81	-348.1	-279.38	Upgrade
Net Income Growth	-	84.52%	-	-	-	-	Upgrade
Shares Outstanding (Basic)	146	145	142	135	132	115	Upgrade
Shares Outstanding (Diluted)	162	160	149	135	132	115	Upgrade
Shares Change (YoY)	11.64%	7.96%	9.67%	2.41%	14.64%	30.51%	Upgrade
EPS (Basic)	3.06	0.16	0.09	-1.65	-2.63	-2.42	Upgrade
EPS (Diluted)	2.78	0.15	0.09	-1.65	-2.63	-2.42	Upgrade
EPS Growth	-	68.03%	-	-	-	-	Upgrade
Free Cash Flow	-70.24	-40.56	-31.41	-176.18	-296.04	-214.86	Upgrade
Free Cash Flow Per Share	-0.43	-0.25	-0.21	-1.30	-2.24	-1.86	Upgrade
Gross Margin	85.34%	88.30%	93.95%	90.48%	88.19%	100.00%	Upgrade
Operating Margin	19.32%	12.74%	8.83%	-7838.99%	-5154.28%	-179996.05%	Upgrade
Profit Margin	84.13%	7.11%	5.42%	-8036.34%	-5204.08%	-183803.29%	Upgrade
Free Cash Flow Margin	-13.21%	-12.33%	-13.44%	-6326.18%	-4425.70%	-141357.90%	Upgrade
EBITDA	102.83	42	20.84	-218.01	-344.49	-273.44	Upgrade
EBITDA Margin	19.33%	12.77%	8.92%	-	-	-	Upgrade
D&A For EBITDA	0.05	0.07	0.21	0.3	0.28	0.16	Upgrade
EBIT	102.78	41.93	20.63	-218.32	-344.77	-273.59	Upgrade
EBIT Margin	19.32%	12.74%	8.83%	-	-	-	Upgrade
Effective Tax Rate	-	8.64%	2.99%	-	-	-	Upgrade
Revenue as Reported	531.9	329	233.66	2.79	6.69	0.15	Upgrade

Updated Nov 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q